Literature DB >> 18190569

Factors impacting on length of stay and mortality of community-acquired pneumonia.

J Garau1, F Baquero, E Pérez-Trallero, J-L Pérez, A M Martín-Sánchez, C García-Rey, J E Martín-Herrero, R Dal-Ré.   

Abstract

A 1-year retrospective multicentre study was performed to identify factors influencing hospital length of stay (LOS) and mortality of patients (n = 3233) admitted to hospital because of community-acquired pneumonia (CAP). Pneumonia severity index (PSI) high-risk classes (IV and V), positive blood culture, admission to an intensive care unit (ICU), multi-lobar involvement and alcohol consumption were associated independently with prolonged LOS. Tobacco smoking was associated with a reduced LOS. The LOS varied markedly among centres. Only PSI high-risk class, admission to ICU and multi-lobar involvement were associated with early, late and global mortality. Positive blood cultures, antimicrobial therapy according to treatment guidelines and the establishment of an aetiological diagnosis were linked to reduced late and global mortality. These data suggest that early mortality associated with CAP is highly dependent on the clinical status of the patient at presentation. Conversely, late mortality seems to be associated more closely with clinical management factors; hence, an aetiological diagnosis and compliance with appropriate therapeutic guidelines have a significant influence on outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18190569     DOI: 10.1111/j.1469-0691.2007.01915.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

Review 1.  Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

Authors:  James D Chalmers; Pallavi Mandal; Aran Singanayagam; Ahsan R Akram; Gourab Choudhury; Philip M Short; Adam T Hill
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

2.  The Impact of Patient Profiles and Procedures on Hospitalization Costs through Length of Stay in Community-Acquired Pneumonia Patients Based on a Japanese Administrative Database.

Authors:  Hironori Uematsu; Susumu Kunisawa; Kazuto Yamashita; Yuichi Imanaka
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

3.  High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Authors:  Matheus Silva Alves; Marilha da Silva Cariolano; Hivylla Lorrana Dos Santos Ferreira; Elen Sousa de Abreu Silva; Karen Karollynny Pereira Felipe; Silvio Gomes Monteiro; Eduardo Martins de Sousa; Afonso Gomes Abreu; Lee Ann Campbell; Michael E Rosenfeld; Mario Hiroyuki Hirata; Rosario Dominguez Crespo Hirata; Gisele Medeiros Bastos; Ilana Cristina de Paula Abreu Silva; Lidio Gonçalves Lima-Neto
Journal:  Braz J Microbiol       Date:  2020-01-30       Impact factor: 2.476

4.  Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study.

Authors:  Binod Neupane; Stephen D Walter; Paul Krueger; Tom Marrie; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-05-11       Impact factor: 3.921

Review 5.  Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART.

Authors:  Catia Cillóniz; Antonella Ielpo; Antoni Torres
Journal:  Curr Infect Dis Rep       Date:  2018-09-10       Impact factor: 3.725

6.  Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Authors:  Isabelle Suter-Widmer; Mirjam Christ-Crain; Werner Zimmerli; Werner Albrich; Beat Mueller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2012-05-20       Impact factor: 3.317

7.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

8.  The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia.

Authors:  Cornelis P C de Jager; Peter C Wever; Eugenie F A Gemen; Ron Kusters; Arianne B van Gageldonk-Lafeber; Tom van der Poll; Robert J F Laheij
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

9.  Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.

Authors:  Francesco Blasi; Javier Garau; Jesús Medina; Marco Ávila; Kyle McBride; Helmut Ostermann
Journal:  Respir Res       Date:  2013-04-15

Review 10.  Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Christophe Marti; Nicolas Garin; Olivier Grosgurin; Antoine Poncet; Christophe Combescure; Sebastian Carballo; Arnaud Perrier
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.